Forte Biosciences, Inc. at its AGM held on September 19, 2023, approved appointment of Chris McIntyre and Michael G. Hacke as directors.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.63 USD | -1.56% | -13.40% | -23.33% |
May. 13 | Tocagen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Mar. 18 | Forte Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-23.33% | 22.93M | |
+8.29% | 114B | |
+10.21% | 104B | |
-11.90% | 22.41B | |
+0.29% | 22.28B | |
-5.57% | 19.07B | |
-37.36% | 18B | |
-5.17% | 17.89B | |
+7.70% | 14.28B | |
+37.65% | 12.55B |
- Stock Market
- Equities
- FBRX Stock
- News Forte Biosciences, Inc.
- Forte Biosciences, Inc. Announces Directorate Appointments